These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17180830)

  • 1. Anticoagulation for stroke prevention.
    Gross B; Lampl Y
    Isr Med Assoc J; 2006 Nov; 8(11):779-83. PubMed ID: 17180830
    [No Abstract]   [Full Text] [Related]  

  • 2. Choosing treatment for a PFO-related neurologic event.
    Romanic BM; Wolfe W
    JAAPA; 2000 Mar; 13(3):89-90, 93. PubMed ID: 11503406
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients].
    Reicke B; Masuhr F; Weih M
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):391-5. PubMed ID: 18604772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent foramen ovale and the risk of cryptogenic stroke.
    Schrale RG; Mitchell AR; Ormerod OJ
    J Am Coll Cardiol; 2006 Nov; 48(9):1913-4; author reply 1914. PubMed ID: 17084271
    [No Abstract]   [Full Text] [Related]  

  • 5. PFO management: neurologists vs cardiologists.
    Messé SR; Cucchiara B; Luciano J; Kasner SE
    Neurology; 2005 Jul; 65(1):172-3. PubMed ID: 16009920
    [No Abstract]   [Full Text] [Related]  

  • 6. [2 cases of atrial septal defects associated with myocardial infarct--autopsy studies].
    Kobayashi M; Shiohara Y; Suzuki Y; Kato K; Oono T
    Nihon Rinsho; 1977 Aug; 35(8):2615-8. PubMed ID: 926349
    [No Abstract]   [Full Text] [Related]  

  • 7. PFO closure for prevention of recurrent stroke in patients after cryptogenic stroke: the imperative of completing randomized controlled trials.
    Kaplan AV; Lukovits TG; Robb JF
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):6-8. PubMed ID: 17173274
    [No Abstract]   [Full Text] [Related]  

  • 8. To close or not to close: PFO, sex and cerebrovascular events.
    Ferguson T; Sansing LH; Herrmann H; Cucchiara B
    J Invasive Cardiol; 2006 Dec; 18(12):E292-3. PubMed ID: 17197717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous devices for stroke prevention.
    Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
    Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation: stroke prevention in patients with atrial fibrillation.
    Waldo AL
    Med Clin North Am; 2008 Jan; 92(1):143-59, xi. PubMed ID: 18061002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial septal defect and hyperhomocysteinemia: two culprits for a cryptogenic stroke.
    Famularo G; Pino GP; Minisola G
    Ann Ital Med Int; 2004; 19(4):288-9. PubMed ID: 15678711
    [No Abstract]   [Full Text] [Related]  

  • 12. [The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention].
    Neundörfer B
    Fortschr Neurol Psychiatr; 2008 Jul; 76(7):383-4. PubMed ID: 18604771
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulation: stroke prevention in patients with atrial fibrillation.
    Waldo AL
    Cardiol Clin; 2009 Feb; 27(1):125-35, ix. PubMed ID: 19111769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and intracardiac right-to-left shunt. Complicating inferior myocardial infarction with right ventricular extension.
    Morris AL; Donen N
    Arch Intern Med; 1978 Sep; 138(9):1405-6. PubMed ID: 686933
    [No Abstract]   [Full Text] [Related]  

  • 15. New device for stroke prevention in atrial fibrillation as an alternative to anticoagulation drugs.
    Lobodzinski SS
    Cardiol J; 2009; 16(4):375-8. PubMed ID: 19653186
    [No Abstract]   [Full Text] [Related]  

  • 16. Cryptogenic stroke in a boy with atrial septal defect and hyperhomocysteinemia.
    Indolfi G; Bartolini E; Trapani S; Azzari C; Resti M
    J Child Neurol; 2008 Sep; 23(9):1070-1. PubMed ID: 18474934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation for elderly patients with atrial fibrillation: not to be neglected.
    Taggar JS; Lip GY
    Europace; 2008 Jan; 10(1):1-2. PubMed ID: 17906285
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of stroke in patients with atrial fibrillation.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation.
    Hammwöhner M; Goette A
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):18-27. PubMed ID: 18594479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.